(R)-methanandamide,
AM-356,
AM356,
arachidonyl-1'-hydroxy-2'-propylamide,
methanandamide,
methanandamide,
(R)-methanandamide,
R(+)-Methanandamide,
AM-356,
(R)-(+)-Methanandamide,
CHEMBL120526,
157182-49-5,
N-(1R-methyl-2-hydroxy-ethyl) arachidonoyl amine,
N-(1R-methyl-2-hydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine,
(5Z,8Z,11Z,14Z)-N-[(2R)-1-hydroxypropan-2-yl]icosa-5,8,11,14-tetraenamide,
(R)-N-(2-Hydroxy-1-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide,
R-1 Methanandamide,
R-(+)-methanandamide,
BSPBio_001285,
SCHEMBL338871,
AC1O424C,
BML2-C03,
GTPL2506,
BCBcMAP01_000201,
SQKRUBZPTNJQEM-FQPARAGTSA-N,
HMS1361A07,
HMS1791A07,
HMS1989A07,
HMS3402A07,
HMS3649D09,
ZINC8860468,
1088AH,
BDBM50054472,
LMFA08020040,
MFCD00467914,
AKOS024456397,
IDI1_033755,
NCGC00161309-01,
NCGC00161309-02,
NCGC00161309-03,
NCGC00161309-04,
R(+)-Arachidonyl-1'-hydroxy-2'-propylamide,
N-(1R-methyl-2-hydroxy-ethyl)arachidonoylamide,
SR-01000946643,
J-009387,
SR-01000946643-1,
BRD-K97602563-001-02-7,
(R)-(+)-Methanandamide (in Tocrisolvetrade mark 100),
(R)-(+)-Arachidonyl-1\\ffffff92-hydroxy-2\\ffffff92-propylamide,
R(+)-Methanandamide, 5 mg/mL in absolute ethanol, >=96% (HPLC),
(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid ((R)-2-hydroxy-1-methyl-ethyl)-amide,
5,8,11,14-Eicosatetraenamide,N-[(1R)-2-hydroxy-1-methylethyl]-,(5Z,8Z,11Z,14Z)-,
R(+)-Arachidonyl-1 inverted exclamation marka-hydroxy-2 inverted exclamation marka-propylamide,
D0I4YK,
C23H39NO2,
CID6321351,
5,8,11,14-Eicosatetraenamide,N-[(1R)-2-hydroxy-1-methylethyl]-, (5Z,8Z,11Z,14Z)-,